drugset / Trial / NCT00576277

Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of AV411 in Neuropathic Pain

NCT00576277

Phase 1/2 Completed 36 enrolled Avigen
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine the safety, tolerability and pharmacokinetics of AV411 after single and multiple doses in patients with chronic neuropathic pain due to diabetes.

Timeline

Start
2006-09
Primary completion
Completion
2007-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Ibudilast Small molecule

Indications